July 6, 2026 Earnings AbbVie Lowers Annual Profit Guidance Amid Billion-Dollar Acquisition June 22, 2026 Earnings AbbVie buys Apogee for $10.9 billion as immunology sales accelerate June 22, 2026 Deals AbbVie to Buy Apogee Therapeutics in $10.9 Billion All-Cash Deal